Evidence map›Paper›PMID 41665687›Full record

ArticleEuropean journal of pediatrics2026

Microbial characteristics and risk factors in PICU with freshwater drowning-associated pneumonia.

Nan Zhang, Xiaojing Zhang, Yuxin Guo, Yafeng Zheng, Wei Gai, Baoli Zhu, Zihao Yang

Abstract read
In one paragraph

Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nan ZhangDepartment of Pediatric Intensive Care Unit, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' health and Diseases, 3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang, China.
Xiaojing ZhangWillingMed Technology (Beijing) Co., Ltd., Beijing, China.
Yuxin GuoWillingMed Technology (Beijing) Co., Ltd., Beijing, China.
Yafeng ZhengWillingMed Technology (Beijing) Co., Ltd., Beijing, China.
Wei GaiWillingMed Technology (Beijing) Co., Ltd., Beijing, China.
Baoli ZhuCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Zihao YangDepartment of Pediatric Intensive Care Unit, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' health and Diseases, 3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang, China. 6200038@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drowning-associated pneumonia (DAP) is the most common infectious complication in drowning patients admitted to the pediatric intensive care unit (PICU). We aim to describe the clinical features, emergency interventions, microbiological characteristics, and antibacterial treatment strategies for children who have drowned, ando analyze the correlation between these factors and their prognosis. This retrospective study enrolled 141 children admitted to the PICU following freshwater drowning between 2019 and 2024. The cohort was stratified by the occurrence of DAP, with comparisons conducted on baseline characteristics, clinical outcomes, pathogen spectrum, and treatment. A logistic regression model was employed to identify risk factors for 28-day post-discharge mortality. Among the 141 pediatric patients admitted to the PICU due to drowning, 71 were diagnosed with DAP and 70 without (Non-DAP). No significant differences were found in the frequency distributions between the two groups when comparing time intervals from submersion to chest compressions and the duration of chest compressions, using a 5-minute cutoff (P > 0.05). Although the DAP group experienced significantly longer hospital and PICU stays, they demonstrated a markedly lower mortality rate at discharge (18.31% vs 41.43%, P = 0.003) and 28-day post-discharge (22.54% vs. 47.14%, P = 0.002) compared to the Non-DAP group. The Pediatric Risk of Mortality (PRISM) score  and hypoxic-ischemic encephalopathy (HIE) were independent risk factors, while a longer length of hospital stay was served as a protective factor for 28-day post-discharge mortality. Microbiological analysis showed that the most commonly detected pathogens were Staphylococcus aureus and Mycoplasma pneumoniae, Candida albicans and rhinovirus. Combination therapy was significantly more frequent in the DAP group (63.38% vs 41.51%), and the use of linezolid was significantly higher in this group than in the Non-DAP group (36.62% vs. 8.57%, P = 0.001).

conclusionsDAP is a frequently observed complication in PICU patients following drowning incidents, but it is not associated with increased mortality among these children. Staphylococcus aureus is a frequently identified pathogen in pediatric DAP, underscoring the need for empirical antibiotic therapy to cover Gram-positive bacteria. WHAT IS KNOWN: • Drowning is a leading cause of pediatric ICU admission. • Drowning-associated pneumonia is common and poses diagnostic challenges, prompting the use of empiric broad-spectrum antibiotics. WHAT IS NEW: • In this pediatric cohort, DAP was associated with longer hospital and PICU stays, but not with increase mortality. • Staphylococcus aureus was the most prevalent pathogen, underscoring the need for Gram-positive bacterial coverage in empirical therapy.

Indexed as

DrowningPneumoniaAnti-Bacterial AgentsChildChild, PreschoolFemaleFresh WaterHumansInfantIntensive Care Units, PediatricMaleRetrospective StudiesRisk FactorsAnti-Bacterial AgentsDrowning-associated pneumoniaOutcomesPathogenPediatricTreatment

Identifiers

PMID41665687
PMCPMC12891081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.